RXRX - RECURSION PHARMACEUTICALS, INC.
IEX Last Trade
7.66
-0.115 -1.501%
Share volume: 330,661
Last Updated: Thu 26 Dec 2024 08:30:26 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$7.78
-0.12
-1.48%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-09 | 2022-11-08 | 2023-02-27 | 2023-05-08 | 2023-08-08 | 2023-11-09 | 2024-02-29 | 2024-05-09 | |
| Total revenue | 7.674 M | 13.160 M | 13.676 M | 12.134 M | 11.017 M | 10.533 M | 10.891 M | 13.794 M | |
| Cost of revenue | 14.227 M | 15.409 M | 10.840 M | 12.448 M | 9.382 M | 10.877 M | 9.880 M | 11.166 M | |
| Gross profit | -6.553 M | -2.249 M | 2.836 M | -314.000 K | 1.635 M | -344.000 K | 1.011 M | 2.628 M | |
| 65.68% | 226.10% | -111.07% | 620.70% | -121.04% | 393.90% | 159.94% | |||
| Operating expenses | 59.638 M | 60.324 M | 63.818 M | 69.551 M | 83.350 M | 99.206 M | 99.941 M | 98.968 M | |
| Selling general and admin | 21.199 M | 19.488 M | 19.838 M | 22.874 M | 28.290 M | 29.199 M | 30.459 M | 31.408 M | |
| Research and development | 38.439 M | 40.836 M | 43.980 M | 46.677 M | 55.060 M | 70.007 M | 69.482 M | 67.560 M | |
| Total expenses | 73.865 M | 75.733 M | 74.658 M | 81.999 M | 92.732 M | 110.083 M | 109.821 M | 110.134 M | |
| 2.53% | -1.42% | 9.83% | 13.09% | 18.71% | -0.24% | 0.29% | |||
| Operating income | -66.191 M | -62.573 M | -60.982 M | -69.865 M | -81.715 M | -99.550 M | -98.930 M | -96.340 M | |
| Ebit | -66.191 M | -62.573 M | -60.982 M | -69.865 M | -81.715 M | -99.550 M | -98.930 M | -96.340 M | |
| Pretax income | -65.560 M | -60.445 M | -57.492 M | -65.327 M | -76.726 M | -93.017 M | -97.058 M | -92.152 M | |
| -7.80% | -4.89% | 13.63% | 17.45% | 21.23% | 4.34% | -5.05% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | -4.062 M | -779.000 K | |
| Net income basic | -65.560 M | -60.445 M | -57.492 M | -65.327 M | -76.726 M | -93.017 M | -92.996 M | -91.373 M | |
| 7.80% | 4.89% | -13.63% | -17.45% | -21.23% | 0.02% | 1.75% | |||
| Net income | -65.560 M | -60.445 M | -57.492 M | -65.327 M | -76.726 M | -93.017 M | -92.996 M | -91.373 M | |
| 7.80% | 4.89% | -13.63% | -17.45% | -21.23% | 0.02% | 1.75% |